Igor F. Palacios
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Igor F. Palacios has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
Ignacio Inglessis
9 shared publications- Ignacio Cruz-González
Department of Cardiology, Hospital Universitario de Salamanca, CIBERCV, IBSAL, Spain (A.S., I.C.-G.).
6 shared publications - Sammy Elmariah
Cardiology Division, University of California, San Francisco (S.E.).
5 shared publications - Eyal Ben-Assa
Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA
4 shared publications - Dhaval Kolte
Harvard Medical School
3 shared publications - Fabio V. Lima
Cardiovascular Institute, Warren Alpert Medical School of Brown University, Providence, Rhode Island
3 shared publications
Latest Publications
- 14 October 2024
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 17 (19) , 2317-2319
PFO Closure in Patients Older Than 60 Years
- 14 October 2024
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 17 (19) , 2317-2319
PFO Closure in Patients Older Than 60 Years
- 1 February 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 165, 81-87
Relation of Subacute Kidney Injury to Mortality After Transcatheter Aortic Valve Implantation
- 1 February 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 165, 81-87
Relation of Subacute Kidney Injury to Mortality After Transcatheter Aortic Valve Implantation
- 16 June 2021
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (4) , 800-807
Efficacy and safety of percutaneous patent foramen ovale closure in patients with a hypercoagulable disorder
Background Transcatheter closure of patent foramen ovale (PFO) in patients with cryptogenic stroke reduces the rate of recurrent events. Although presence of thrombophilia increases the risk for paradoxical emboli through a PFO, such patients were excluded from large randomized trials. Objectives We compared the safety and efficacy of percutaneous PFO closure in patients with and without a hypercoagulable state. Methods Data from 800 consecutive patients undergoing percutaneous PFO closure in our medical center were analyzed. All patients were independently evaluated by specialists in neurology, cardiology, hematology, and vascular medicine. A post-procedural treatment of at least 3 months of anticoagulation was utilized in patients with thrombophilia. Follow-up events included death, recurrent neurological events, and the need for reintervention for significant residual shunt. Results A hypercoagulable state was found in 239 patients (29.9%). At median follow-up of 41.9 months, there were no differences in the frequencies of stroke or transient ischemic attack between patients with or without thrombophilia (2.5% in non-hypercoagulable group vs. 3.4% in hypercoagulable group, log-rank test p = 0.35). There were no significant differences in baseline demographics, echocardiographic characteristics, procedural success, or complications between groups. Conclusion Percutaneous PFO closure is a safe and effective therapeutic approach for patients with cryptogenic stroke and an underlying hypercoagulable state.
- 16 June 2021
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 98 (4) , 800-807
Efficacy and safety of percutaneous patent foramen ovale closure in patients with a hypercoagulable disorder
Background Transcatheter closure of patent foramen ovale (PFO) in patients with cryptogenic stroke reduces the rate of recurrent events. Although presence of thrombophilia increases the risk for paradoxical emboli through a PFO, such patients were excluded from large randomized trials. Objectives We compared the safety and efficacy of percutaneous PFO closure in patients with and without a hypercoagulable state. Methods Data from 800 consecutive patients undergoing percutaneous PFO closure in our medical center were analyzed. All patients were independently evaluated by specialists in neurology, cardiology, hematology, and vascular medicine. A post-procedural treatment of at least 3 months of anticoagulation was utilized in patients with thrombophilia. Follow-up events included death, recurrent neurological events, and the need for reintervention for significant residual shunt. Results A hypercoagulable state was found in 239 patients (29.9%). At median follow-up of 41.9 months, there were no differences in the frequencies of stroke or transient ischemic attack between patients with or without thrombophilia (2.5% in non-hypercoagulable group vs. 3.4% in hypercoagulable group, log-rank test p = 0.35). There were no significant differences in baseline demographics, echocardiographic characteristics, procedural success, or complications between groups. Conclusion Percutaneous PFO closure is a safe and effective therapeutic approach for patients with cryptogenic stroke and an underlying hypercoagulable state.
- 10 August 2020
- Published by Saber UCV in Gaceta Médica de Caracas
- Vol. 128 (3) , 296-306
Current status of transcatheter closure of patent foramen ovale
A patent foramen ovale (PFO) is a highly prevalent structure among the adult population. It allows the shunt of blood through the inter-atrial septum and has been associated with cryptogenic stroke, transient ischemic attack, significant right to left shunting resulting in resting and exercise-induced hypoxemia, platypnea orthodeoxia syndrome, and decompression sickness after scuba diving and migraines. Currently, transthoracic and transesophageal echocardiography and transcranial Doppler are the most important diagnostic tools, for the diagnosis of PFO. The sensitivity and specificity of the study depend on the modalities available: transthoracic (TTE), transesophageal (TEE), and transcranial Doppler (TCD), as well as the intravenous use of agitated saline and the site of injection.
- 10 August 2020
- Published by Saber UCV in Gaceta Médica de Caracas
- Vol. 128 (3) , 296-306
Current status of transcatheter closure of patent foramen ovale
A patent foramen ovale (PFO) is a highly prevalent structure among the adult population. It allows the shunt of blood through the inter-atrial septum and has been associated with cryptogenic stroke, transient ischemic attack, significant right to left shunting resulting in resting and exercise-induced hypoxemia, platypnea orthodeoxia syndrome, and decompression sickness after scuba diving and migraines. Currently, transthoracic and transesophageal echocardiography and transcranial Doppler are the most important diagnostic tools, for the diagnosis of PFO. The sensitivity and specificity of the study depend on the modalities available: transthoracic (TTE), transesophageal (TEE), and transcranial Doppler (TCD), as well as the intravenous use of agitated saline and the site of injection.
- Open Access
- 11 September 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (509)
Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis
High left ventricular stroke work and low vascular impedance predict better quality of life after valve intervention in patients with aortic stenosis.
- 11 September 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (509)
Open AccessVentricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis
High left ventricular stroke work and low vascular impedance predict better quality of life after valve intervention in patients with aortic stenosis.